封面
市场调查报告书
商品编码
1529570

组织和器官移植市场:按产品类型、移植类型、应用、最终用户和地区

Tissue and Organ Transplantation Market, By Product Type, By Type of Transplant, By Application , By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球组织和器官移植市场规模为171.1亿美元,预计2031年将达321亿美元,2024年至2031年复合年增长率为9.4%。

报告范围 报告详情
基准年 2023年 2024年市场规模 171.1亿美元
实际资料 2019-2023 预测期 2024年至2031年
预测 2024-2031 年复合年增长率: 9.40% 2031年价值预测 321亿美元
图:2024 年按地区分類的组织和器官移植市场占有率(%)
组织器官移植市场-IMG1

组织/器官移植是一种将组织或器官从一个人转移到另一个人以修復、替换或增强受体器官或组织功能的外科手术。组织和器官移植是世界上发展最快的医学专业之一。组织和器官衰竭对人们的生活产生巨大影响,但移植给世界各地数百万患者带来了希望。由于文明病和交通事故导致的器官衰竭率不断上升,推动了全球对组织和器官移植的需求。移植技术和预防移植排斥的免疫抑制疗法的进步也推动了市场的成长。

市场动态:

全球组织和器官移植市场的成长主要是由于导致器官衰竭的慢性病和文明病的盛行率上升所推动的。此外,世界上不断增加的老年人口也推动了对替代组织和器官的需求。据世界卫生组织称,65岁及以上的人口预计将从2010年的5.24亿增加到2050年的近15亿。此外,移植技术的技术进步和开拓更有效的免疫抑制药物来预防器官排斥可能为市场相关人员提供新的机会。然而,与组织/器官移植手术相关的高成本和相容器官的短缺可能会阻碍市场成长。对器官贩运的道德担忧和对器官捐赠的宗教禁令可能会阻碍可移植器官的供应。

本研究的主要特点

  • 该报告对全球组织和器官移植市场进行了详细分析,以2023年为基准年估计了预测期内(2024-2031年)的市场规模(十亿美元)和年复合成长率(CAGR%)。发布。
  • 它还揭示了各个细分市场的潜在商机,并解释了该市场中有吸引力的投资提案的矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数,介绍了全球组织和器官移植市场的主要企业。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球组织和器官移植市场报告针对该行业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球组织和器官移植市场的各种策略矩阵,将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球组织与器官移植市场:冠状病毒(COVID-19)大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球组织与器官移植市场,依产品类型,2019-2031 年(十亿美元)

  • 纸巾产品
  • 保存液
  • 免疫抑制药物

第六章 全球组织与器官移植市场,依移植类型,2019-2031 年(十亿美元)

  • 活体移植
  • 尸体捐赠者移植
  • 自体移植
  • 异种移植
  • 同种异体移植

第七章 全球组织与器官移植市场,依应用分类,2019-2031 年(十亿美元)

  • 器官移植
  • 组织移植

第 8 章 全球组织与器官移植市场,依最终使用者划分,2019-2031 年(十亿美元)

  • 医院
  • 移植中心
  • 组织函式库
  • 其他的

第九章 全球组织与器官移植市场,按地区,2019-2031 年(十亿美元)

  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东

第10章竞争格局

  • 公司简介
    • BD(Becton, Dickinson and Company)
    • LabWare
    • Zimmer Biomet Holdings Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Medtronic PLC
    • Abbott
    • OrganOX Limited
    • Terumo Corporation
    • TransMedics Inc.
    • BioLife Solutions Inc.
    • Teva Pharmaceuticals
    • F. Hoffmann-La Roche Ltd.
    • Stryker Corporation
    • CryoLife Inc.
    • Abbvie, Inc.
    • Arthrex, Inc.

第十一章分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第十二章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI4342

Global tissue and organ transplantation market is estimated to be valued at USD 17.11 Bn in 2024 and is expected to reach USD 32.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 17.11 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 9.40% 2031 Value Projection: US$ 32.10 Bn
Figure. Tissue and Organ Transplantation Market Share (%), By Region 2024
Tissue and Organ Transplantation Market - IMG1

Tissue and organ transplantation refers to the surgical procedure of transferring tissues or organs from one person to another person to repair, replace or enhance the function of the recipient's organ or tissue. The transplantation of tissues and organs has become one of the most rapidly growing specialty areas of medicine in the world. Tissue and organ failure profoundly impact people's lives, however transplantation offers hope for millions of patients worldwide. Growing rates of organ failure due to lifestyle diseases and road accidents have boosted demand for tissue and organ transplantation globally. Advancements in transplantation techniques and immunosuppressive therapies that prevent rejection of transplants can also drive the market growth.

Market Dynamics:

Global tissue and organ transplantation market growth is primarily driven by rising prevalence of chronic diseases and lifestyle disorders resulting in organ failure. Growing geriatric population worldwide is also boosts demand for replacement tissues and organs. According to WHO, the number of people aged 65 years and older is projected to increase from 524 million in 2010 to nearly 1.5 billion in 2050. Furthermore, technological advancements in transplant procedures and development of more effective immunosuppressant drugs to prevent organ rejection can offer new opportunities for market players. However, high costs associated with tissue and organ transplantation surgeries and shortage of matching organs can hamper the market growth. Ethical concerns over organ trafficking and religious prohibitions on organ donations can hamper the supply of transplantable organs.

Key Features of the Study:

  • This report provides in-depth analysis of the global tissue and organ transplantation market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global tissue and organ transplantation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, 21st Century Medicine, BiolifeSolutions, CryoLife, Lonza Group
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global tissue and organ transplantation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue and organ transplantation market

Detailed Segmentation-

  • By Product Type
    • Tissue Products
    • Preservation Solution
    • Immunosuppressive Drugs
  • By Type of Transplant
    • Living Donor Transplant
    • Deceased Donor Transplant
    • Autograft Transplant
    • Xenograft Transplant
    • Allograft Transplant
  • By Application
    • Organ Transplantation
    • Tissue Transplantation
  • By End User
    • Hospital
    • Transplant Centers
    • Tissue Banks
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • BD (Becton, Dickinson and Company)
    • LabWare
    • Zimmer Biomet Holdings Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Medtronic PLC
    • Abbott
    • OrganOX Limited
    • Terumo Corporation
    • TransMedics Inc.
    • BioLife Solutions Inc.
    • Teva Pharmaceuticals
    • Hoffmann-La Roche Ltd.
    • Stryker Corporation
    • CryoLife Inc.
    • Abbvie, Inc
    • Arthrex, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Type of Transplant
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Tissue and Organ Transplantation Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Tissue and Organ Transplantation Market, By Product Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Tissue Products
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Preservation Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Immunosuppressive Drugs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Tissue and Organ Transplantation Market, By Type of Transplant, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Living Donor Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Deceased Donor Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Autograft Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Xenograft Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Allograft Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Tissue and Organ Transplantation Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Organ Transplantation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Tissue Transplantation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Tissue and Organ Transplantation Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospital
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Transplant Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Tissue Banks
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Tissue and Organ Transplantation Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • BD (Becton, Dickinson and Company)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LabWare
    • Zimmer Biomet Holdings Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Medtronic PLC
    • Abbott
    • OrganOX Limited
    • Terumo Corporation
    • TransMedics Inc.
    • BioLife Solutions Inc.
    • Teva Pharmaceuticals
    • F. Hoffmann-La Roche Ltd.
    • Stryker Corporation
    • CryoLife Inc.
    • Abbvie, Inc.
    • Arthrex, Inc.

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact